Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingjun Zhang

Showing results (371-380 of 386) with videos related to

Pageof 39
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2014
Origin of myofibroblasts in the fibrotic liver in miceKeiko Iwaisako, Chunyan Jiang, Mingjun Zhang, et al.
Circulation|February 10, 2025
Exploring Origin-Dependent Susceptibility of Smooth Muscle Cells to Aortic Diseases Through Intersectional GeneticsXimeng Han, Yi Li, Enci Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 27, 2025
Deciphering Neural Mechanisms Underlying Marmoset Dynamic Natural Behaviors Using a Miniaturized Wireless Large-Scale Coverage Neural RecorderHongru Liu, Xinyuan Cao, Jiyong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2020
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300Lynn M Williams, Fiona E McCann, Marisa A Cabrita, et al.
Cell Stem Cell|February 10, 2021
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targetingXimeng Han, Zhenqian Zhang, Lingjuan He, et al.
Med (New York, N.Y.)|June 13, 2024
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trialZi-Xian Wang, Junjie Peng, Xinjun Liang, et al.
BMC Medicine|July 6, 2025
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinomaQiang Xu, Xue Zhao, Xianze Wang, et al.
BMJ (Clinical Research Ed.)|March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trialZhi Peng, Yanqiao Zhang, Huiting Xu, et al.
Plos One|March 12, 2020
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organsMingjun Zhang, Michael Haughey, Nai-Yu Wang, et al.
Signal Transduction and Targeted Therapy|July 27, 2025
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS<sup>G12C</sup> inhibitor-naïve Chinese patients with KRAS<sup>G12C</sup>-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studiesYing Yuan, Yanhong Deng, Yongdong Jin, et al.
Pageof 39

Showing results (371-380 of 386) with videos related to

Sort By:
Pageof 39
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2014
Origin of myofibroblasts in the fibrotic liver in miceKeiko Iwaisako, Chunyan Jiang, Mingjun Zhang, et al.
Circulation|February 10, 2025
Exploring Origin-Dependent Susceptibility of Smooth Muscle Cells to Aortic Diseases Through Intersectional GeneticsXimeng Han, Yi Li, Enci Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 27, 2025
Deciphering Neural Mechanisms Underlying Marmoset Dynamic Natural Behaviors Using a Miniaturized Wireless Large-Scale Coverage Neural RecorderHongru Liu, Xinyuan Cao, Jiyong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2020
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300Lynn M Williams, Fiona E McCann, Marisa A Cabrita, et al.
Cell Stem Cell|February 10, 2021
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targetingXimeng Han, Zhenqian Zhang, Lingjuan He, et al.
Med (New York, N.Y.)|June 13, 2024
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trialZi-Xian Wang, Junjie Peng, Xinjun Liang, et al.
BMC Medicine|July 6, 2025
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinomaQiang Xu, Xue Zhao, Xianze Wang, et al.
BMJ (Clinical Research Ed.)|March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trialZhi Peng, Yanqiao Zhang, Huiting Xu, et al.
Plos One|March 12, 2020
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organsMingjun Zhang, Michael Haughey, Nai-Yu Wang, et al.
Signal Transduction and Targeted Therapy|July 27, 2025
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS<sup>G12C</sup> inhibitor-naïve Chinese patients with KRAS<sup>G12C</sup>-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studiesYing Yuan, Yanhong Deng, Yongdong Jin, et al.
Pageof 39